Literature DB >> 23599251

Challenges in the treatment of major depressive disorder with psychotic features.

Anthony J Rothschild1.   

Abstract

Psychotic depression is associated with significant morbidity and mortality but is underdiagnosed and undertreated. In recent years, there have been several studies that have increased our knowledge regarding the optimal treatment of patients with psychotic depression. The combination of an antidepressant and antipsychotic is significantly more effective than either antidepressant monotherapy or antipsychotic monotherapy for the acute treatment of psychotic depression. Most treatment guidelines recommend either the combination of an antidepressant with an antipsychotic or ECT for the treatment of an acute episode of unipolar psychotic depression. The optimal maintenance treatment after a person responds to either the antidepressant/antipsychotic combination or the ECT is unclear particularly as it pertains to length of time the patient needs to take the antipsychotic medication. Little is known regarding the optimal treatment of a patient with bipolar disorder who has an episode of psychotic depression or the clinical characteristics of responders to medication treatments vs ECT treatments.

Entities:  

Keywords:  delusional depression; major depression with psychotic features; psychotic depression

Mesh:

Substances:

Year:  2013        PMID: 23599251      PMCID: PMC3686458          DOI: 10.1093/schbul/sbt046

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  79 in total

1.  Treatment setting and clinical depression.

Authors:  E S Paykel; G L Klerman; B A Prusoff
Journal:  Arch Gen Psychiatry       Date:  1970-01

Review 2.  The treatment of psychotic depression: is there consensus among guidelines and psychiatrists?

Authors:  Anne Katrine K Leadholm; Anthony J Rothschild; Willem A Nolen; Per Bech; Povl Munk-Jørgensen; Søren Dinesen Ostergaard
Journal:  J Affect Disord       Date:  2012-09-27       Impact factor: 4.839

3.  Environmental and familial risk factors for psychotic and non-psychotic severe depression.

Authors:  Søren Dinesen Ostergaard; Berit Lindum Waltoft; Preben Bo Mortensen; Ole Mors
Journal:  J Affect Disord       Date:  2012-12-07       Impact factor: 4.839

4.  The validity of major depression with psychotic features based on a community study.

Authors:  J Johnson; E Horwath; M M Weissman
Journal:  Arch Gen Psychiatry       Date:  1991-12

5.  Missed diagnosis of psychotic depression at 4 academic medical centers.

Authors:  Anthony J Rothschild; Jesse Winer; Alastair J Flint; Benoit H Mulsant; Ellen M Whyte; Moonseong Heo; Susan Fratoni; Michelle Gabriele; Sonja Kasapinovic; Barnett S Meyers
Journal:  J Clin Psychiatry       Date:  2008-08       Impact factor: 4.384

6.  A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD).

Authors:  Barnett S Meyers; Alastair J Flint; Anthony J Rothschild; Benoit H Mulsant; Ellen M Whyte; Catherine Peasley-Miklus; Eros Papademetriou; Andrew C Leon; Moonseong Heo
Journal:  Arch Gen Psychiatry       Date:  2009-08

7.  Psychotic (delusional) depression: a meta-analysis of physical treatments.

Authors:  G Parker; K Roy; D Hadzi-Pavlovic; F Pedic
Journal:  J Affect Disord       Date:  1992-01       Impact factor: 4.839

8.  Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.

Authors:  Heike E Künzel; Nibal Ackl; Martin Hatzinger; Katja Held; Edith Holsboer-Trachsler; Marcus Ising; Wolfgang Kaschka; Siegfried Kasper; Anastasios Konstantinidis; Annette Sonntag; Manfred Uhr; Alexander Yassouridis; Florian Holsboer; Axel Steiger
Journal:  J Psychiatr Res       Date:  2008-11-26       Impact factor: 4.791

9.  Cognitively-oriented psychotherapy for early psychosis (COPE). Preliminary results.

Authors:  H Jackson; P McGorry; J Edwards; C Hulbert; L Henry; S Francey; D Maude; J Cocks; P Power; S Harrigan; P Dudgeon
Journal:  Br J Psychiatry Suppl       Date:  1998

10.  Proposed delusional depression subtypes: preliminary evidence from a retrospective study of phenomenology and treatment course.

Authors:  T A Aronson; S Shukla; A Hoff; B Cook
Journal:  J Affect Disord       Date:  1988 Jan-Feb       Impact factor: 4.839

View more
  18 in total

1.  Psychotic depression: an underappreciated window to explore the dimensionality and pathobiology of psychosis.

Authors:  John L Waddington; Peter F Buckley
Journal:  Schizophr Bull       Date:  2013-05-24       Impact factor: 9.306

Review 2.  [Delusional depression : Diagnostics, phenomenology and therapy].

Authors:  M Bürgy
Journal:  Nervenarzt       Date:  2017-05       Impact factor: 1.214

3.  Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission: The STOP-PD II Randomized Clinical Trial.

Authors:  Alastair J Flint; Barnett S Meyers; Anthony J Rothschild; Ellen M Whyte; George S Alexopoulos; Matthew V Rudorfer; Patricia Marino; Samprit Banerjee; Cristina D Pollari; Yiyuan Wu; Aristotle N Voineskos; Benoit H Mulsant
Journal:  JAMA       Date:  2019-08-20       Impact factor: 56.272

4.  Persistent delusional theme over 13 episodes of psychotic depression.

Authors:  S D Ostergaard; A K Leadholm; A J Rothschild
Journal:  Acta Neuropsychiatr       Date:  2013-12       Impact factor: 3.403

5.  Investigating the Role of Acceptance, Mindfulness, and Values in Patients with Psychosis in the Context of Depression.

Authors:  Brandon A Gaudiano; Jennifer Primack; Ivan W Miller
Journal:  J Psychiatr Intensive Care       Date:  2016-09

6.  Epidemiological and clinical characterization following a first psychotic episode in major depressive disorder: comparisons with schizophrenia and bipolar I disorder in the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS).

Authors:  Olabisi Owoeye; Tara Kingston; Paul J Scully; Patrizia Baldwin; David Browne; Anthony Kinsella; Vincent Russell; Eadbhard O'Callaghan; John L Waddington
Journal:  Schizophr Bull       Date:  2013-05-28       Impact factor: 9.306

7.  Metabotropic glutamate receptor mGluR2/3 and mGluR5 binding in the anterior cingulate cortex in psychotic and nonpsychotic depression, bipolar disorder and schizophrenia: implications for novel mGluR-based therapeutics.

Authors:  Natalie Matosin; Francesca Fernandez-Enright; Elisabeth Frank; Chao Deng; Jenny Wong; Xu-Feng Huang; Kelly A Newell
Journal:  J Psychiatry Neurosci       Date:  2014-11       Impact factor: 6.186

8.  Recognition and management of depression in early psychosis.

Authors:  Zainab Bashir; Sian Lowri Griffiths; Rachel Upthegrove
Journal:  BJPsych Bull       Date:  2022-04

9.  Patterns of psychotropic medication use in inpatient and outpatient psychiatric settings in Saudi Arabia.

Authors:  Fahad D Alosaimi; Abdulhadi Alhabbad; Mohammed F Abalhassan; Ebtihaj O Fallata; Nasser M Alzain; Mohammad Zayed Alassiry; Bander Abdullah Haddad
Journal:  Neuropsychiatr Dis Treat       Date:  2016-04-19       Impact factor: 2.570

10.  Self-Reported Adverse Drug Reactions, Medication Adherence, and Clinical Outcomes among Major Depressive Disorder Patients in Ethiopia: A Prospective Hospital Based Study.

Authors:  Tadesse Melaku Abegaz; Lamessa Melese Sori; Hussien Nurahmed Toleha
Journal:  Psychiatry J       Date:  2017-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.